Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5889)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2013 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen K, Zhang H, Zhang LN, Ju SQ, Qi J, Huang DF, Li F, Wei Q, Zhang J. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma. World J Gastroenterol 2013; 19(20): 3143-3149 [PMID: 23716996 DOI: 10.3748/wjg.v19.i20.3143] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i20/3143.htm |
| Number | Citing Articles |
| 1 |
Jessica A. Howell, Shahid A. Khan, Susanne Knapp, Mark R. Thursz, Rohini Sharma. The clinical role of circulating free tumor DNA in gastrointestinal malignancy. Translational Research 2017; 183: 137 doi: 10.1016/j.trsl.2016.12.006
|
| 2 |
Bin Sun, Zhi Huang, Bi Wang, Yanglong Yu, Shihai Lin, Lei Luo, Yuzhu Wang, Zheng Huang. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis. Medical Science Monitor 2017; 23: 850 doi: 10.12659/MSM.899198
|
| 3 |
Vincent L. Chen, Dabo Xu, Max S. Wicha, Anna S. Lok, Neehar D. Parikh. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review. Clinical Gastroenterology and Hepatology 2020; 18(13): 2879 doi: 10.1016/j.cgh.2020.04.019
|
| 4 |
Qi Zhao, Yiqiu Xu, Dandan Yuan, Junjun Yang, Ying Wang, Guorong Shen, Xuewen Huang, Nashwa El-Khazragy. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/9958909
|
| 5 |
E. Scalici, S. Traver, N. Molinari, T. Mullet, M. Monforte, E. Vintejoux, S. Hamamah. Cell-free DNA in human follicular fluid as a biomarker of embryo quality. Human Reproduction 2014; 29(12): 2661 doi: 10.1093/humrep/deu238
|
| 6 |
Swati Kumari, Shikha Tewari, Nuzhat Husain, Akash Agarwal, Anshuman Pandey, Ashish Singhal, Mohtashim Lohani. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer. Pathology & Oncology Research 2017; 23(1): 91 doi: 10.1007/s12253-016-0087-0
|
| 7 |
Yun Jiang, Wei Zong, Shaoqing Ju, Rongrong Jing, Ming Cui. Promising member of the short interspersed nuclear elements (Alu elements): mechanisms and clinical applications in human cancers. Journal of Medical Genetics 2019; 56(10): 639 doi: 10.1136/jmedgenet-2018-105761
|
| 8 |
Vincent L. Chen, Neehar D. Parikh. Liquid Biopsy for Hepatocellular Carcinoma. Current Hepatology Reports 2019; 18(4): 390 doi: 10.1007/s11901-019-00491-z
|
| 9 |
Francesca Pezzuto, Luigi Buonaguro, Franco Buonaguro, Maria Tornesello. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(4): 1007 doi: 10.3390/ijms19041007
|
| 10 |
Jia Jie Li, Yanqing Lv, Huifan Ji. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis. PeerJ 2022; 10: e14303 doi: 10.7717/peerj.14303
|
| 11 |
Florian Roßner, Bruno Valentin Sinn, David Horst. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers 2023; 15(2): 494 doi: 10.3390/cancers15020494
|
| 12 |
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Mutation Research/Reviews in Mutation Research 2019; 781: 100 doi: 10.1016/j.mrrev.2019.05.002
|
| 13 |
T B Hao, W Shi, X J Shen, J Qi, X H Wu, Y Wu, Y Y Tang, S Q Ju. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. British Journal of Cancer 2014; 111(8): 1482 doi: 10.1038/bjc.2014.470
|
| 14 |
Rasha Elzehery, Narmin Effat, Reham El Farahaty, Raghda Elsayed Farag, Ekbal M Abo-Hashem, Rania Elhelaly. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 158(2): 254 doi: 10.1093/ajcp/aqac037
|
| 15 |
Mahsa Salehi, Zohre Miri Lavasani, Hani Keshavarz Alikhani, Bahare Shokouhian, Moustapha Hassan, Mustapha Najimi, Massoud Vosough. Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma. Cells 2023; 12(18): 2260 doi: 10.3390/cells12182260
|
| 16 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2022; : 761 doi: 10.1007/978-3-030-41683-6_50
|
| 17 |
Wenjun Liao, Yilei Mao, Penglei Ge, Huayu Yang, Haifeng Xu, Xin Lu, Xinting Sang, Shouxian Zhong. Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma. Medicine 2015; 94(14): e722 doi: 10.1097/MD.0000000000000722
|
| 18 |
Jessica A Howell, Rohini Sharma. The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma. Hepatic Oncology 2016; 3(1): 45 doi: 10.2217/hep.15.38
|
| 19 |
Jinmei Zhang, Yuan Yuan, Shuxia Gao, Xue Zhao, Hong Li. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis. Biomarkers in Medicine 2021; 15(3): 219 doi: 10.2217/bmm-2020-0334
|
| 20 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
| 21 |
Yuling Gan, Qiuzhen Liang, Xinghua Song. Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysis. Tumor Biology 2014; 35(5): 3953 doi: 10.1007/s13277-013-1563-8
|
| 22 |
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary Malignancies. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
|
| 23 |
Luca Sigalotti, Alessia Covre, Francesca Colizzi, Elisabetta Fratta. Cell-free DNA as Diagnostic Markers. Methods in Molecular Biology 2019; 1909: 137 doi: 10.1007/978-1-4939-8973-7_11
|
| 24 |
Haiyan Liu, Lin Ma, Shenghao Xu, Wenhao Hua, Jin Ouyang. Using metal nanoparticles as a visual sensor for the discrimination of proteins. J. Mater. Chem. B 2014; 2(22): 3531 doi: 10.1039/C4TB00252K
|
| 25 |
Katsunori Sakamoto, Kohei Ogawa, Kei Tamura, Masahiko Honjo, Kyosei Sogabe, Chihiro Ito, Miku Iwata, Akimasa Sakamoto, Mikiya Shine, Yusuke Nishi, Mio Uraoka, Tomoyuki Nagaoka, Naotake Funamizu, Yasutsugu Takada. Diagnostic value of quantification of cell‐free DNA for suspected gallbladder cancer. JGH Open 2023; 7(11): 748 doi: 10.1002/jgh3.12977
|
| 26 |
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver disease. Annals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
|
| 27 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_50-1
|
| 28 |
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?. Cancers 2021; 13(9): 2274 doi: 10.3390/cancers13092274
|
| 29 |
Daniel R A Cox, William Chung, Josephine Grace, Darren Wong, Numan Kutaiba, Dinesh Ranatunga, Richard Khor, Marcos V Perini, Michael Fink, Robert Jones, Mark Goodwin, Alex Dobrovic, Adam Testro, Vijayaragavan Muralidharan. Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment. JGH Open 2023; 7(4): 249 doi: 10.1002/jgh3.12879
|
| 30 |
Lanjing Zhang. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 95 doi: 10.1007/978-3-319-68082-8_6
|
| 31 |
Lirong Wei, Wangxi Wu, Liming Han, Weimo Yu, Yuzhen Du. A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA. Oncology Letters 2018; doi: 10.3892/ol.2018.9198
|
| 32 |
L. Cabel, C. Proudhon, B. Buecher, J.-Y. Pierga, F.-C. Bidard. Circulating tumor DNA detection in hepatocellular carcinoma. Annals of Oncology 2018; 29(5): 1094 doi: 10.1093/annonc/mdy111
|
| 33 |
|
| 34 |
Ting Wang, Kun-He Zhang, Piao-Ping Hu, Qin-Si Wan, Fang-Li Han, Jian-Ming Zhou, De-Qiang Huang, Nong-Hua Lv. Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases. Oncotarget 2017; 8(58): 97758 doi: 10.18632/oncotarget.22050
|
| 35 |
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Keiji Nishibeppu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Eigo Otsuji. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 2017; 23(31): 5650-5668 doi: 10.3748/wjg.v23.i31.5650
|
| 36 |
Jing Xu, Yuanyuan Zhao, Zhishui Chen, Lai Wei. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma. Journal of Personalized Medicine 2024; 14(4): 420 doi: 10.3390/jpm14040420
|
| 37 |
Guo Long, Tongdi Fang, Wenxin Su, Xingyu Mi, LeDu Zhou. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2020; 55(12): 1441 doi: 10.1080/00365521.2020.1839127
|
| 38 |
Wang Jian, Chen Huanqiu, Yue Chao. Utilizing circulating free DNA in diagnosing early gastric cancer in a patient with situs inversus totalis: A case report and literature review. Precision Medical Sciences 2021; 10(2): 90 doi: 10.1002/prm2.12037
|
| 39 |
Michail Galanopoulos, Nikolaos Tsoukalas, Ioannis S Papanikolaou, Maria Tolia, Maria Gazouli, Gerassimos J Mantzaris. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World Journal of Gastrointestinal Oncology 2017; 9(4): 142-152 doi: 10.4251/wjgo.v9.i4.142
|
| 40 |
Manal Mohamed Kamal, Ashraf Omar Abdelaziz, Heba Nabil El-Baz, Ghada Maher Mohamed, Samaa Salama Saleh, Mohamed Mahmoud Nabeel, Tamer Mahmoud Elbaz, Rania Lithy, Hend Ibrahim Shousha. Plasma cell-free DNA integrity index and hepatocellular carcinoma treated or not with direct-acting antivirals: A case-control study. Arab Journal of Gastroenterology 2022; 23(1): 39 doi: 10.1016/j.ajg.2021.12.006
|